{
  "id": 16188315,
  "title": "Biotech takes a hit as dealmakers take a knee in Q3",
  "url": "https://urgent.news/2026/10/23/biotech-takes-a-hit-as-dealmakers-take-a-knee-in-q3",
  "topic": "world",
  "section": "World",
  "published": "2026-10-23T13:00:17.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/biotech-takes-a-hit-as-dealmakers-take-a-knee-in-q3/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A chill wind blew through the biopharma industry in the third quarter as the pace of M&A from the first half of the year cooled down, big upfront licensing deals slackened and venture investing slowed ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}